Filing Flows › Harvard Bioscience (HBIO) › Q2 2026 › vs Q1 2026
Harvard Bioscience (HBIO) Q2 2026 vs Q1 2026 (quarter over quarter)
Harvard Bioscience's revenue rose $2.0M (+10%) from $20.8M in Q1 2026 to $22.7M in Q2 2026. The biggest changes: Instruments, Equipment, Software, and Accessories +$1.7M (+9%); Service, Maintenance, and Warranty Contracts +$234K (+11%).
Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Instruments, Equipment, Software, and Accessories | $20.3M | $18.6M | $1.7M | +9% |
| Service, Maintenance, and Warranty Contracts | $2.4M | $2.2M | $234K | +11% |
| Revenue | $22.7M | $20.8M | $2.0M | +10% |
| Net loss | $2.9M | $3.4M | −$514K | -15% |
| Costs & expenses | $25.6M | $24.2M | $1.5M | +6% |
| Operating costs | $23.7M | $21.9M | $1.8M | +8% |
| Interest & other, net | $1.9M | $2.1M | −$215K | -10% |
| Income tax | $14K | $117K | −$103K | -88% |
| Cost of revenue | $10.1M | $8.5M | $1.6M | +19% |
| Research & development | $2.5M | $2.3M | $127K | +5% |
| Sales & marketing | $5.4M | $5.3M | $65K | +1% |
| General & admin | $4.6M | $4.7M | −$85K | -2% |
| Other operating costs | $1.1M | $1.1M | $83K | +8% |
| Operating cash sources | $3.2M | $2.8M | $473K | +17% |
| Depreciation & amortization | $1.3M | $1.3M | $24K | +2% |
| Share-based compensation | $380K | $257K | $123K | +48% |
| Working capital & other | $1.6M | $1.2M | $326K | +26% |
| Net loss absorbed | $2.9M | $3.4M | −$514K | -15% |
| Operating cash flow | $325K | −$662K | $987K | — |
| Capital expenditures | $688K | $426K | $262K | +62% |
| Negative free cash flow (OCF − capex) | $363K | $1.1M | −$725K | -67% |
Questions
How much did Harvard Bioscience's revenue grow quarter over quarter in Q2 2026?
Harvard Bioscience's revenue rose $2.0M (+10%) from $20.8M in Q1 2026 to $22.7M in Q2 2026.
What drove Harvard Bioscience's revenue change in Q2 2026?
Instruments, Equipment, Software, and Accessories +$1.7M (+9%); Service, Maintenance, and Warranty Contracts +$234K (+11%).